Profile data is unavailable for this security.
About the company
Diagnos Inc. is a Canadian company, which is engaged in the early detection of critical eye-related health problems using advanced technology based on Artificial Intelligence (AI). It markets Computer Assisted Retinal Analysis (CARA), a software platform which assists health specialists in the detection of certain retinopathy pathologies through the computerized analysis of retina images. CARA is an in-house-hosted Web-based application that integrates fundus cameras with an image processing engine over a secure Internet connection. The CARA suite of applications allows an eye care specialist to more clearly visualize both normal retinal landmarks (optic nerve, vascular system, macula, fovea), and pathological changes (exudates, haemorrhages, micro-aneurisms, neo-vascularization). CARA is indicated for use by healthcare professionals in an adult general population in the context of a general eye-health exam.
- Revenue in CAD (TTM)68.16k
- Net income in CAD-4.71m
- Incorporated1996
- Employees--
- LocationDiagnos Inc7005 Taschereau Blvd Suite 340BROSSARD J4Z 1A7CanadaCAN
- Phone+1 (450) 678-8882
- Fax+1 (450) 678-8882
- Websitehttps://www.diagnos.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prostar Holdings Inc | 1.29m | -2.16m | 18.52m | -- | -- | -- | -- | 14.36 | -0.0141 | -0.0141 | 0.0083 | -0.0028 | 2.22 | -- | 20.95 | -- | -372.20 | -170.59 | -- | -275.43 | 69.75 | 81.21 | -167.48 | -575.94 | -- | -- | -- | -- | 21.06 | -- | 48.74 | -- | -- | -- |
| IC Group Holdings Inc | 19.78m | -3.80m | 26.84m | -- | -- | 4.85 | -- | 1.36 | -0.1762 | -0.1762 | 0.8413 | 0.1339 | 1.11 | -- | -- | -- | -21.35 | -- | -54.02 | -- | 45.49 | -- | -19.22 | -- | -- | -2.78 | 0.6855 | -- | -- | -- | -252.71 | -- | -- | -- |
| Diagnos Inc | 68.16k | -4.71m | 36.12m | -- | -- | 23.92 | -- | 529.98 | -0.045 | -0.045 | 0.0007 | 0.0125 | 0.0192 | -- | 5.56 | -- | -132.61 | -181.53 | -519.48 | -556.38 | -2,090.82 | -194.74 | -6,907.20 | -992.58 | -- | -9.56 | 0.5579 | -- | -39.00 | -20.72 | -37.36 | -- | -1.94 | -- |
| Pivotree Inc | 70.16m | 3.50m | 44.78m | -- | 12.83 | 0.8794 | 5.46 | 0.6382 | 0.1325 | 0.1325 | 2.66 | 1.93 | 1.25 | -- | 7.10 | -- | 6.21 | -11.98 | 7.16 | -14.64 | 45.17 | 45.98 | 4.98 | -11.36 | -- | -- | 0.0066 | -- | -12.88 | 5.56 | -64.43 | -- | -11.22 | -- |
